Metabolic Disease Drugs Market, Global Outlook and Forecast 2023-2029

Report ID: MMG61186 | Category: Pharma & Healthcare | Pages: 66 | Format: PDF | Published Date: February 28,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Metabolic disease mainly covers Glycogen Metabolism Disease, Lipid Metabolism Disease, Amino Acid Metabolism, Metal Metabolism Disease, etc.
This report aims to provide a comprehensive presentation of the global market for Metabolic Disease Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metabolic Disease Drugs. This report contains market size and forecasts of Metabolic Disease Drugs in global, including the following market information:
Global Metabolic Disease Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Metabolic Disease Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Glycogen Metabolism Disease Drug Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Metabolic Disease Drugs include Merck, Novartis, Takeda Pharmaceutical, Astra Zeneca, Beohrigher Ingelheim, KOWA, Kythera, Fuji yakuhin and LG Life Science, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Metabolic Disease Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Metabolic Disease Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Metabolic Disease Drugs Market Segment Percentages, by Type, 2022 (%)
    Glycogen Metabolism Disease Drug
    Lipid Metabolism Disease Drug
    Amino Acid Metabolism Drug
    Other
Global Metabolic Disease Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Metabolic Disease Drugs Market Segment Percentages, by Application, 2022 (%)
    Hospital Pharmacy
    Retail Pharmacy
Global Metabolic Disease Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Metabolic Disease Drugs Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Metabolic Disease Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Metabolic Disease Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Merck
    Novartis
    Takeda Pharmaceutical
    Astra Zeneca
    Beohrigher Ingelheim
    KOWA
    Kythera
    Fuji yakuhin
    LG Life Science
    Metsubishi Tanabe Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Metabolic Disease Drugs, market overview.
Chapter 2: Global Metabolic Disease Drugs market size in revenue.
Chapter 3: Detailed analysis of Metabolic Disease Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Metabolic Disease Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Metabolic Disease Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Metabolic Disease Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Metabolic Disease Drugs Overall Market Size
    2.1 Global Metabolic Disease Drugs Market Size: 2022 VS 2029
    2.2 Global Metabolic Disease Drugs Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Metabolic Disease Drugs Players in Global Market
    3.2 Top Global Metabolic Disease Drugs Companies Ranked by Revenue
    3.3 Global Metabolic Disease Drugs Revenue by Companies
    3.4 Top 3 and Top 5 Metabolic Disease Drugs Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Metabolic Disease Drugs Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Metabolic Disease Drugs Players in Global Market
        3.6.1 List of Global Tier 1 Metabolic Disease Drugs Companies
        3.6.2 List of Global Tier 2 and Tier 3 Metabolic Disease Drugs Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Metabolic Disease Drugs Market Size Markets, 2022 & 2029
        4.1.2 Glycogen Metabolism Disease Drug
        4.1.3 Lipid Metabolism Disease Drug
        4.1.4 Amino Acid Metabolism Drug
        4.1.5 Other
    4.2 By Type - Global Metabolic Disease Drugs Revenue & Forecasts
        4.2.1 By Type - Global Metabolic Disease Drugs Revenue, 2018-2023
        4.2.2 By Type - Global Metabolic Disease Drugs Revenue, 2024-2029
        4.2.3 By Type - Global Metabolic Disease Drugs Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Metabolic Disease Drugs Market Size, 2022 & 2029
        5.1.2 Hospital Pharmacy
        5.1.3 Retail Pharmacy
    5.2 By Application - Global Metabolic Disease Drugs Revenue & Forecasts
        5.2.1 By Application - Global Metabolic Disease Drugs Revenue, 2018-2023
        5.2.2 By Application - Global Metabolic Disease Drugs Revenue, 2024-2029
        5.2.3 By Application - Global Metabolic Disease Drugs Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Metabolic Disease Drugs Market Size, 2022 & 2029
    6.2 By Region - Global Metabolic Disease Drugs Revenue & Forecasts
        6.2.1 By Region - Global Metabolic Disease Drugs Revenue, 2018-2023
        6.2.2 By Region - Global Metabolic Disease Drugs Revenue, 2024-2029
        6.2.3 By Region - Global Metabolic Disease Drugs Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Metabolic Disease Drugs Revenue, 2018-2029
        6.3.2 US Metabolic Disease Drugs Market Size, 2018-2029
        6.3.3 Canada Metabolic Disease Drugs Market Size, 2018-2029
        6.3.4 Mexico Metabolic Disease Drugs Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Metabolic Disease Drugs Revenue, 2018-2029
        6.4.2 Germany Metabolic Disease Drugs Market Size, 2018-2029
        6.4.3 France Metabolic Disease Drugs Market Size, 2018-2029
        6.4.4 U.K. Metabolic Disease Drugs Market Size, 2018-2029
        6.4.5 Italy Metabolic Disease Drugs Market Size, 2018-2029
        6.4.6 Russia Metabolic Disease Drugs Market Size, 2018-2029
        6.4.7 Nordic Countries Metabolic Disease Drugs Market Size, 2018-2029
        6.4.8 Benelux Metabolic Disease Drugs Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Metabolic Disease Drugs Revenue, 2018-2029
        6.5.2 China Metabolic Disease Drugs Market Size, 2018-2029
        6.5.3 Japan Metabolic Disease Drugs Market Size, 2018-2029
        6.5.4 South Korea Metabolic Disease Drugs Market Size, 2018-2029
        6.5.5 Southeast Asia Metabolic Disease Drugs Market Size, 2018-2029
        6.5.6 India Metabolic Disease Drugs Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Metabolic Disease Drugs Revenue, 2018-2029
        6.6.2 Brazil Metabolic Disease Drugs Market Size, 2018-2029
        6.6.3 Argentina Metabolic Disease Drugs Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Metabolic Disease Drugs Revenue, 2018-2029
        6.7.2 Turkey Metabolic Disease Drugs Market Size, 2018-2029
        6.7.3 Israel Metabolic Disease Drugs Market Size, 2018-2029
        6.7.4 Saudi Arabia Metabolic Disease Drugs Market Size, 2018-2029
        6.7.5 UAE Metabolic Disease Drugs Market Size, 2018-2029
7 Metabolic Disease Drugs Companies Profiles
    7.1 Merck
        7.1.1 Merck Company Summary
        7.1.2 Merck Business Overview
        7.1.3 Merck Metabolic Disease Drugs Major Product Offerings
        7.1.4 Merck Metabolic Disease Drugs Revenue in Global Market (2018-2023)
        7.1.5 Merck Key News & Latest Developments
    7.2 Novartis
        7.2.1 Novartis Company Summary
        7.2.2 Novartis Business Overview
        7.2.3 Novartis Metabolic Disease Drugs Major Product Offerings
        7.2.4 Novartis Metabolic Disease Drugs Revenue in Global Market (2018-2023)
        7.2.5 Novartis Key News & Latest Developments
    7.3 Takeda Pharmaceutical
        7.3.1 Takeda Pharmaceutical Company Summary
        7.3.2 Takeda Pharmaceutical Business Overview
        7.3.3 Takeda Pharmaceutical Metabolic Disease Drugs Major Product Offerings
        7.3.4 Takeda Pharmaceutical Metabolic Disease Drugs Revenue in Global Market (2018-2023)
        7.3.5 Takeda Pharmaceutical Key News & Latest Developments
    7.4 Astra Zeneca
        7.4.1 Astra Zeneca Company Summary
        7.4.2 Astra Zeneca Business Overview
        7.4.3 Astra Zeneca Metabolic Disease Drugs Major Product Offerings
        7.4.4 Astra Zeneca Metabolic Disease Drugs Revenue in Global Market (2018-2023)
        7.4.5 Astra Zeneca Key News & Latest Developments
    7.5 Beohrigher Ingelheim
        7.5.1 Beohrigher Ingelheim Company Summary
        7.5.2 Beohrigher Ingelheim Business Overview
        7.5.3 Beohrigher Ingelheim Metabolic Disease Drugs Major Product Offerings
        7.5.4 Beohrigher Ingelheim Metabolic Disease Drugs Revenue in Global Market (2018-2023)
        7.5.5 Beohrigher Ingelheim Key News & Latest Developments
    7.6 KOWA
        7.6.1 KOWA Company Summary
        7.6.2 KOWA Business Overview
        7.6.3 KOWA Metabolic Disease Drugs Major Product Offerings
        7.6.4 KOWA Metabolic Disease Drugs Revenue in Global Market (2018-2023)
        7.6.5 KOWA Key News & Latest Developments
    7.7 Kythera
        7.7.1 Kythera Company Summary
        7.7.2 Kythera Business Overview
        7.7.3 Kythera Metabolic Disease Drugs Major Product Offerings
        7.7.4 Kythera Metabolic Disease Drugs Revenue in Global Market (2018-2023)
        7.7.5 Kythera Key News & Latest Developments
    7.8 Fuji yakuhin
        7.8.1 Fuji yakuhin Company Summary
        7.8.2 Fuji yakuhin Business Overview
        7.8.3 Fuji yakuhin Metabolic Disease Drugs Major Product Offerings
        7.8.4 Fuji yakuhin Metabolic Disease Drugs Revenue in Global Market (2018-2023)
        7.8.5 Fuji yakuhin Key News & Latest Developments
    7.9 LG Life Science
        7.9.1 LG Life Science Company Summary
        7.9.2 LG Life Science Business Overview
        7.9.3 LG Life Science Metabolic Disease Drugs Major Product Offerings
        7.9.4 LG Life Science Metabolic Disease Drugs Revenue in Global Market (2018-2023)
        7.9.5 LG Life Science Key News & Latest Developments
    7.10 Metsubishi Tanabe Pharma
        7.10.1 Metsubishi Tanabe Pharma Company Summary
        7.10.2 Metsubishi Tanabe Pharma Business Overview
        7.10.3 Metsubishi Tanabe Pharma Metabolic Disease Drugs Major Product Offerings
        7.10.4 Metsubishi Tanabe Pharma Metabolic Disease Drugs Revenue in Global Market (2018-2023)
        7.10.5 Metsubishi Tanabe Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Metabolic Disease Drugs Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?